>>> Up
* Aker Solutions Raised to Overweight at JPMorgan; PT 61 kroner
* Arcadium Lithium Raised to Neutral at Piper Sandler; PT $5.85
* Arcadium Lithium Raised to Neutral at Piper Sandler; PT $5.85
* Beijer REF Raised to Buy at ABG; PT 190 kronor
* DiaSorin SpA Raised to Outperform at Mediobanca SpA
* INVISIO AB Raised to Buy at SEB Equities; PT 295 kronor
* Lithium Americas Raised to Outperform at National Bank
* Lufthansa Raised to Hold at Stifel; PT 6.50 euros
* Ontex Raised to Hold at Kepler Cheuvreux
>>> Down
>>> Down
* Aena Cut to Neutral at JB Capital Markets; PT 226 euros
* ASML Cut to Hold at DZ Bank; PT 650 euros
* DiaSorin SpA Cut to Hold at HSBC; PT 105 euros
* Eramet Cut to Sell at Stifel; PT 45 euros
* Givaudan Cut to Neutral at Citi; PT 4,650 Swiss francs
* Jenoptik Cut to Hold at Stifel; PT 26 euros
* Nel Cut to Hold at HSBC; PT 4.30 kroner
* Novavax PT Cut to $25 from $31 at Jefferies
* Novavax PT Cut to $25 from $31 at Jefferies
* Orkla Cut to Hold at Nordea
* Qiagen Cut to Hold at HSBC; PT 45 euros
* Subsea 7 Cut to Neutral at JPMorgan; PT 200 kroner
* Uber Cut to Neutral at Daiwa; PT $84
>>> Initiation
>>> Initiation
* AbbVie Rated New Market Perform at Bernstein; PT $203
* Amgen Rated New Outperform at Bernstein; PT $380
* Bristol Myers Rated New Market Perform at Bernstein; PT $56
* Constellation Energy Rated New Overweight at JPMorgan; PT $342
* Eli Lilly Rated New Outperform at Bernstein; PT $1,100
* Gilead Rated New Outperform at Bernstein; PT $105
* Lonza Rated New Buy at Kepler Cheuvreux; PT 630 Swiss francs
* Merck & Co Rated New Market Perform at Bernstein; PT $115
* Moderna Rated New Market Perform at Bernstein; PT $55
* Moderna Rated New Market Perform at Bernstein; PT $55
* Pfizer Rated New Market Perform at Bernstein; PT $32
* Ventura Offshore Holding Rated New Buy at ABG; PT 45 kroner
>>> Call
>>> Call
* Endesa a Hold at Jefferies, Regulatory Upside Mainly Priced In
* Givaudan’s Earnings Growth Limited in 2025, Citi Downgrades
* Goldman’s Trading Desk Sees S&P 500 Reaching 6,270 by Year-End
* Buy DAX Strangles to Play SAP Earnings, JPMorgan Strategists Say
* Novonesis Cut at Citi, Growth Expectations Difficult to Achieve